Redx Pharma (REDX)

Company name:Redx Pharma Plc
EPIC:REDXTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BSNB6S51
Market Segment:ASQ1Share Type:DE
WWW Address: 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 60.00 2.5 [4.35] 55.00 65.00 60.00 60.00 60.00 9,886
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 75.89 126.48 -0.03 -3.40 - - - 92.50 - 5.00

Redx Pharma Key Figures

(at previous day's close)
Market Cap.75.89m
Shares In Issue126.48m
Prev. Close57.50
PE Ratio- 
Dividend Yield-%
EPS - basic-3.40p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-3.69p
Return On Equity (ROE)-289.60%
Operating Margin-202.33%
PEG Factor- 
EPS Growth Rate51.43%
Dividends PS Growth Rate-%
Net Debt1.16m
Gross Gearing76.55%
Quick Assets5.81m
Net Working Capital0.94m
Intangibles / Fixed Assets75.68%
Turnover PS2.48p
Pre-Tax Profit PS-5.01p
Retained Profit PS-3.41p
Cash PS2.93p
Net Cash PS-0.92p
Net Tangible Asset Value PS *0.85p
Net Asset Value PS1.18p
Spread10.00 (15.38%) 

Redx Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week61.5057.50
4 weeks67.5057.50
12 weeks85.0055.00
1 year92.505.00

Share Price Chart (5 years)

Redx Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week61.50-1.50-2.4457.500.0357.50
4 weeks67.50-7.50-11.1157.500.0362.14
12 weeks85.00-25.00-29.4155.000.0664.39
26 weeks12.5047.50380.0012.500.1349.33
1 year7.0053.00757.145.000.2522.20
3 years23.2536.75158.063.500.1915.83
5 years77.00-17.00-22.083.500.1722.49

Redx Pharma Key Management Ratios

Redx Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 9.10 
Tobin's Q Ratio (excl. intangibles)9.58 
Dividend Yield-%
Market-to-Book Ratio50.90 
Price-to-Pre-Tax Profit PS-11.98 
Price-to-Retained Profit PS-17.57 
Price-to-Cash Flow PS-16.26 
Price-to-Sales PS24.24 
Price-to-Net Tangible Asset Value PS70.66 
Price-to-Cash PS20.49 
Net Working Capital PS0.74 
Price Pct to Working Capital PS80.73%
Earnings Yield-%
Average PE23.13 
Years in average1 
PE to PE average-%

Redx Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing18.29%
Net Gearing (excl. Intangibles)19.58%
Gross Gearing76.55%
Gross Gearing (excl. Intangibles)81.92%
Gearing Under 1 Year76.55%
Gearing Under 1 Year (excl. Intgbl)81.92%
(Liquidity Ratios)
Net Working Capital to Total Assets14.78%
Current Ratio1.19 
Quick Ratio (Acid Test)1.19 
Liquidity Ratio0.76 
Cash & Equiv/Current Assets63.79%
(Solvency Ratios)
Enterprise Value72.18m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.06 
Total Debt/Sales1.55 
Total Debt/Pre-Tax Profit-0.77 
Total Debt4.87m
Total Debt/Net Current Assets5.18%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-24.76%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)

Redx Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-424.88%
Return On Assets (ROA)-51.78%
Net Profit Margin-137.91%
Assets Turnover0.38 
Return On Equity (ROE)-289.60%
Return On Investment (ROI)-109.87%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-137.91%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.86 
Fixed Assets Turnover5.38 
Current Assets Turnover0.40 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales2.66 
Debt Collection Period311.08Days

Redx Pharma Dividends

Sorry No Data Available

Redx Pharma Fundamentals

 30 Sep 2016 (GBP)30 Sep 2017 (GBP)30 Sep 2018 (GBP)30 Sep 2019 (GBP)
pre tax profit-15.41-1.655.40%-10.15--6.34-202.33%m
attributable profit-15.52-1.535.01%-8.85--4.32-137.91%m
retained profit-15.52-1.535.01%-8.85--4.32-137.91%m
eps - basic (p)-19.80 1.40 -7.00 -3.40 
eps - diluted (p)-19.80 1.40 -7.00 -3.40 
dividends per share- - - - 

Redx Pharma Balance Sheet

 30 Sep 2016 (GBP)30 Sep 2017 (GBP)30 Sep 2018 (GBP)30 Sep 2019 (GBP)
 30 Sep 2016 (GBP)30 Sep 2017 (GBP)30 Sep 2018 (GBP)30 Sep 2019 (GBP)
fixed assets fixed assets0.535.67%0.220.80%0.191.85%0.132.11%m
intangibles intangibles0.313.29%0.431.55%0.424.10%0.426.56%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors2.8029.75%3.2311.67%3.2331.34%2.1033.08%m
cash & securities cash & securities5.7661.29%23.8185.98%6.4762.71%3.7058.26%m
creditors - short creditors - short7.6881.69%13.3648.26%3.9538.28%4.8776.55%m
creditors - long creditors - long--%--%0.615.86%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves1.7218.31%14.3351.74%5.7655.86%1.4923.45%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Redx Pharma Cash Flow Statement

30 Sep 2016 (GBP)30 Sep 2017 (GBP)30 Sep 2018 (GBP)30 Sep 2019 (GBP)
Operating CF-12.5114.10-17.18-4.67m
Pre-Financing CF-12.9514.07-17.29-4.64m
Retained CF-3.6818.05-17.34-2.77m

Redx Pharma Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Redx Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201202 23:08:33